Dr. Patrick Ott commented on the increased rates of melanoma in older adults.
Tags: BasicResearch, Melanoma, SkinCancer
Tags: Melanoma, SkinCancer
Tags: Melanoma, Nutrition, Prevention
Dr. F. Stephen Hodi led a clinical trial study that found patients with metastatic melanoma who were treated with ipilimumab, survived 50 percent longer if they simultaneously received an immune stimulant.
Tags: BasicResearch, Melanoma
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: